Loneliness: the real cost to our health

Loneliness is not just a health crisis. It is also a fiscal one. And the older Europe gets, the stronger the economic case for prevention becomes.

Most debates about loneliness focus – rightly – on what it does to those affected: the health risks, the emotional burden, the loss of independence and dignity. But there is a parallel story that is enormously significant for health systems, insurers, employers, and policymakers: what loneliness costs.

The figures are substantial. A 2025 study by the University of Exeter, published in PLOS One, analyzed NHS spending data for 23,071 British adults and found that people who frequently feel lonely incurred around 900 pounds more in health costs per year – including GP visits, outpatient appointments, and inpatient care – than their non-lonely peers. The cost difference grew with age: among older lonely people, it was proportionally larger than among lonely middle-aged adults.

That is one country. One health system. One dataset. Across Europe and North America a consistent picture emerges: loneliness increases utilization, accelerates morbidity, and generates costs that health systems have so far barely captured systematically.

The scale of the economic burden

A systematic review published in BMC Public Health in 2024 – an update of an earlier analysis of the economic literature – brought together results from 15 studies across different countries. Cost-of-illness studies concluded that loneliness and social isolation generate additional costs – predominantly in healthcare and through lost work productivity – ranging from 2 billion US dollars per year in Australia to 25.2 billion US dollars in Spain. At the individual level, annual estimates ranged from 1,196 US dollars per lonely person in Australia to 17,581 US dollars per severely lonely person in the United Kingdom.

The US Medicare program alone spends an estimated 6.7 billion US dollars per year on costs attributable to loneliness – driven by higher hospitalization rates, more frequent emergency department visits, and the treatment of loneliness-related conditions such as depression, cardiovascular disease, and cognitive decline.

These figures should be understood as a conservative lower bound. Researchers point out that existing cost estimates are very likely set too low: they typically capture only direct health expenditure and do not account for informal care costs, productivity losses, the fiscal downstream costs of premature mortality, and the systemic costs of loneliness-related dementia at scale.

Why lonely people use the health system differently

The cost difference is no accident. It follows a predictable pattern rooted in the well-documented health consequences of social isolation.

Lonely people consult GPs more often and visit emergency departments more frequently – often with complaints that have a substantial psychosocial component. Anxiety disorders, sleep disturbances, medically unexplained symptoms, and somatic manifestations of depression increase with social isolation. Without sufficient social support, people also tend to delay seeking medical help until conditions become acute – and then treatment is more expensive.

The Dutch population study by Meisters et al. – one of the methodologically most robust analyses of its kind, based on data from over 342,000 adults – showed that loneliness was associated with 10.3% of annual spending on mental health care. For GP spending, the excess attributable to loneliness amounted to 0.8% of total national GP expenditure. These percentages seem modest; in absolute terms they represent hundreds of millions of euros per year for a mid-sized European country.

The mechanisms are well understood: chronic loneliness activates persistent stress responses, raises inflammatory markers, disrupts sleep architecture, and accelerates the progression of conditions – high blood pressure, type 2 diabetes, cardiovascular disease – each of which is costly to treat in its own right. The condition also significantly raises the likelihood of depression, which in turn is among the most expensive illnesses in any health system.

The German context: an intensifying crisis

Germany faces this challenge under conditions of particularly high structural pressure. Three converging forces raise the economic stakes.

Demographic acceleration. The German population is aging faster than most comparable economies. According to the Federal Statistical Office (Destatis), the number of people in need of care nearly tripled between 1999 and 2023, from 2.02 to 5.69 million. Projections show that by 2039 the number of people aged 67 and over will rise by a further 5 million. This demographic trajectory is structurally guaranteed and will increase the prevalence of loneliness-related conditions.

The shortage of care workers. Germany's care sector is already grappling with a substantial structural deficit. The statutory long-term care insurance associations project that population aging alone will require a further 130,000 long-term care workers by 2030 – before existing vacancies are even taken into account. Fewer care workers mean less social contact for older people in residential facilities, less capacity for home visits, and a further thinning of the social infrastructure that protects against isolation.

The financing gap. The German social insurance system works on a pay-as-you-go basis: the working population finances care for the elderly. The tighter the ratio of contributors to beneficiaries becomes, the more pressure builds on long-term care insurance. The costs of loneliness-related morbidity – higher hospitalization rates, faster onset of care dependency, greater treatment needs in psychiatry – fall directly on this system. Prevention is not just an act of compassion; it is fiscally sensible.

The return on investment of prevention

The economic case for tackling loneliness goes beyond cost containment. The 2024 systematic review found that all five social return on investment (SROI) studies analyzed reported positive returns from loneliness interventions – with SROI ratios between 2.28 and 13.72 US dollars per dollar invested. This means that for every amount invested in measures to reduce loneliness, the evidence suggests a return of between two and fourteen times that amount in avoided health and social costs.

This is not a fringe phenomenon. It reflects a consistent pattern across country contexts and intervention types: group-based social interventions, befriending services, structured community programs, and technology-supported connection offerings generate measurable cost savings that exceed their implementation costs.

A regional economic analysis in Environment and Planning A (Burlina & Rodríguez-Pose, 2023), which evaluated data from European regions, found that a high prevalence of loneliness was associated with a measurably lower regional GDP per capita – and this relationship was driven specifically by reduced frequency of social interaction, not by demographic factors alone. Loneliness is not just a cost driver in healthcare. It is a drag on overall economic performance.

What this means for health systems and payers

For health planners, insurers, and B2B players, the data point to a clear and so far barely used lever: detecting and addressing social isolation early – before it generates acute clinical demand.

The evidence suggests that the most cost-effective interventions share several common features: they target individuals identified as lonely, rather than the population in general; they enable regular, substantial social interaction rather than passive presence; and they work continuously over time rather than as one-off measures.

Crucially, the cost of inaction is not zero. Untreated loneliness accumulates. The health trajectories of socially isolated older people increasingly diverge from those of well-connected peers – faster cognitive decline, higher hospitalization rates, earlier care dependency. Each of these outcomes represents not only a human cost but also a fiscal one, borne primarily by statutory health and long-term care insurance.

Germany has the institutional maturity, the actuarial data, and the demographic urgency to lead in this area. What has been missing until now was the infrastructure to deliver social connection at scale. That is changing. And the economic case for investing in it has never been stronger.